Polymorphisms in matrix metalloproteinases MMP1 and MMP9 are associated with primary open-angle and angle closure

Shazia Micheal1, Sajeela Yousaf, Muhammad Imran Khan

  • 1Department of Biosciences, COMSATS Institute of Information Technology, Islamabad, Pakistan. shaziamicheal@gmail.com

Molecular Vision
|February 27, 2013
PubMed
Abstract

Insights

Genetic variations in MMP1 and MMP9 may be linked to glaucoma in Pakistani women and men, respectively. Further research is recommended to explore these potential gender-dependent risk factors for primary open-angle glaucoma and primary angle closure glaucoma.

Area of Science:

  • Genetics
  • Ophthalmology
  • Molecular Biology

Background:

  • Matrix metalloproteinases (MMPs) are crucial for extracellular matrix remodeling in ocular tissues.
  • Functional polymorphisms in MMP genes have been associated with glaucoma pathogenesis.
  • Understanding genetic predispositions is vital for glaucoma management.

Purpose of the Study:

  • To investigate the association of specific matrix metalloproteinase gene polymorphisms with glaucoma in a Pakistani population.
  • To explore potential gender-specific roles of these polymorphisms in primary open-angle glaucoma (POAG) and primary angle closure glaucoma (PACG).

Main Methods:

  • A case-control study involving 112 POAG patients, 82 PACG patients, and 118 controls.
  • Genotyping of MMP polymorphisms (MMP1 rs1799750, MMP7 c.-181T>C, MMP9 rs17576, MMP9 c.-1562C>T) using PCR and RFLP analysis.
  • Gender stratification was performed for association analyses.

Main Results:

  • MMP1 rs1799750 polymorphism showed a significant association with POAG, particularly in female patients (p < 0.001).
  • MMP9 rs17576 polymorphism was significantly associated with PACG, especially in male patients (p = 0.009).
  • No significant associations were found for MMP7 (c.-181T>C) and MMP9 (c.-1562C>T) polymorphisms.

Conclusions:

  • MMP1 rs1799750 and MMP9 rs17576 polymorphisms may serve as potential gender-dependent risk factors for POAG and PACG in the Pakistani population.
  • These findings warrant further investigation to elucidate the precise mechanisms and clinical implications.
  • Genetic screening for these polymorphisms could aid in identifying individuals at higher risk for specific glaucoma types.

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...